Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity

被引:192
作者
Yan, MH
Marsters, SA
Grewal, IS
Wang, H
Ashkenazi, A
Dixit, VM
机构
[1] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA
关键词
D O I
10.1038/76889
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
B lymphocyte stimulator (BLyS) is a member of the tumor necrosis factor (TNF) superfamily. BLyS stimulates proliferation of, and immunoglobulin production by, B cells. However, the relative importance of BLyS in physiological B cell activation is unclear. We identified a B cell receptor for BLyS through expression cloning as TACI, an orphan TNF receptor homologue of unknown function. Binding of BLyS to TACI activated signaling by nuclear factor-kappa B (NF-kappa). In vitro soluble TACI-Fc fusion protein blocked BLyS-induced NF-kappa B activation in B lymphoma cells and IgM production in peripheral blood B cells. In vivo treatment of immunized mice with TACI-Fc inhibited production of antigen-specific IgM and IgG I antibodies and abolished splenic germinal center (GC) formation.-rhus, BLyS activity must play a critical role in the humoral immune response.
引用
收藏
页码:37 / 41
页数:5
相关论文
共 42 条
[21]   CD28/B7 system of T cell costimulation [J].
Lenschow, DJ ;
Walunas, TL ;
Bluestone, JA .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :233-258
[22]   IMMUNOSUPPRESSION INVIVO BY A SOLUBLE FORM OF THE CTLA-4 T-CELL ACTIVATION MOLECULE [J].
LINSLEY, PS ;
WALLACE, PM ;
JOHNSON, J ;
GIBSON, MG ;
GREENE, JL ;
LEDBETTER, JA ;
SINGH, C ;
TEPPER, MA .
SCIENCE, 1992, 257 (5071) :792-795
[23]   Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations [J].
Mackay, F ;
Woodcock, SA ;
Lawton, P ;
Ambrose, C ;
Baetscher, M ;
Schneider, P ;
Tschopp, J ;
Browning, JL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (11) :1697-1710
[24]  
MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117
[25]   Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B [J].
Marsters, SA ;
Sheridan, JP ;
Donahue, CJ ;
Pitti, RM ;
Gray, CL ;
Goddard, AD ;
Bauer, KD ;
Ashkenazi, A .
CURRENT BIOLOGY, 1996, 6 (12) :1669-1676
[26]   Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappa B and AP-1 [J].
Marsters, SA ;
Ayres, TM ;
Skubatch, M ;
Gray, CL ;
Rothe, M ;
Ashkenazi, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (22) :14029-14032
[27]   Identification of a ligand for the death-domain-containing receptor Apo3 [J].
Marsters, SA ;
Sheridan, JP ;
Pitti, RM ;
Brush, J ;
Goddard, A ;
Ashkenazi, A .
CURRENT BIOLOGY, 1998, 8 (09) :525-528
[28]   Affinity maturation without germinal centres in lymphotoxin-alpha-deficient mice [J].
Matsumoto, M ;
Lo, SF ;
Carruthers, CJL ;
Min, JJ ;
Mariathasan, S ;
Huang, GM ;
Plas, DR ;
Martin, SM ;
Geha, RS ;
Nahm, MH ;
Chaplin, DD .
NATURE, 1996, 382 (6590) :462-466
[29]   LIGHT, a new member of the TNF superfamily, and lymphotoxin α are ligands for herpesvirus entry mediator [J].
Mauri, DN ;
Ebner, R ;
Montgomery, RI ;
Kochel, KD ;
Cheung, TC ;
Yu, GL ;
Ruben, S ;
Murphy, M ;
Eisenberg, RJ ;
Cohen, GH ;
Spear, PG ;
Ware, CF .
IMMUNITY, 1998, 8 (01) :21-30
[30]   BLyS: Member of the tumor necrosis factor family and B lymphocyte stimulator [J].
Moore, PA ;
Belvedere, O ;
Orr, A ;
Pieri, K ;
LaFleur, DW ;
Feng, P ;
Soppet, D ;
Charters, M ;
Gentz, R ;
Parmelee, D ;
Li, YL ;
Galperina, O ;
Giri, J ;
Roschke, V ;
Nardelli, B ;
Carrell, J ;
Sosnovtseva, S ;
Greenfield, W ;
Ruben, SM ;
Olsen, HS ;
Fikes, J ;
Hilbert, DM .
SCIENCE, 1999, 285 (5425) :260-263